0.4527
VolitionRX Ltd stock is traded at $0.4527, with a volume of 724.51K.
It is down -2.46% in the last 24 hours and down -31.00% over the past month.
VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.
See More
Previous Close:
$0.4641
Open:
$0.503
24h Volume:
724.51K
Relative Volume:
3.16
Market Cap:
$48.71M
Revenue:
$1.29M
Net Income/Loss:
$-29.87M
P/E Ratio:
-1.2575
EPS:
-0.36
Net Cash Flow:
$-14.70M
1W Performance:
-29.79%
1M Performance:
-31.00%
6M Performance:
-7.23%
1Y Performance:
-34.63%
VolitionRX Ltd Stock (VNRX) Company Profile
Name
VolitionRX Ltd
Sector
Industry
Phone
646 650 1351
Address
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Compare VNRX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
VNRX
VolitionRX Ltd
|
0.4527 | 49.94M | 1.29M | -29.87M | -14.70M | -0.36 |
![]()
TMO
Thermo Fisher Scientific Inc
|
524.58 | 198.17B | 43.21B | 6.58B | 6.17B | 17.28 |
![]()
DHR
Danaher Corp
|
205.14 | 144.97B | 24.01B | 3.41B | 4.86B | 4.7082 |
![]()
IDXX
Idexx Laboratories Inc
|
633.32 | 49.29B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
138.23 | 38.73B | 6.79B | 1.22B | 1.09B | 4.2644 |
![]()
IQV
Iqvia Holdings Inc
|
203.77 | 33.69B | 15.70B | 1.24B | 2.01B | 6.9036 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-08-25 | Initiated | H.C. Wainwright | Buy |
Feb-01-23 | Downgrade | The Benchmark Company | Buy → Hold |
Feb-17-22 | Resumed | Cantor Fitzgerald | Overweight |
Mar-10-21 | Initiated | Cantor Fitzgerald | Overweight |
May-16-18 | Initiated | Maxim Group | Buy |
May-14-18 | Reiterated | The Benchmark Company | Buy |
Sep-07-16 | Reiterated | Rodman & Renshaw | Buy |
Feb-01-16 | Initiated | Rodman & Renshaw | Buy |
View All
VolitionRX Ltd Stock (VNRX) Latest News
Published on: 2025-10-13 09:58:07 - newser.com
Published on: 2025-10-13 06:57:47 - newser.com
Does VolitionRx Limited show high probability of reboundEntry Point & Free Technical Confirmation Trade Alerts - newser.com
VolitionRx prices $6 million public offering of common stock and warrants By Investing.com - Investing.com South Africa
VolitionRx (VNRX) Sets Pricing for Public Offering of Shares and Warrants - GuruFocus
VolitionRx Prices Public Offering Of 11.55 Mln Shares And Warrants At $0.52/set; Shares Fall - Nasdaq
VolitionRx Limited Announces Pricing of $6.0 Million Underwritten Public Offering of Common Stock and Common Stock Warrants - Yahoo Finance
Levi Strauss, USANA Health Sciences And 3 Stocks To Watch Heading Into Friday - Benzinga
VolitionRx (VNRX) Plans Public Offering to Bolster Development a - GuruFocus
VolitionRx announces proposed public offering of common stock By Investing.com - Investing.com Australia
Volitionrx stock tumbles on proposed public offering By Investing.com - Investing.com South Africa
Volitionrx stock tumbles on proposed public offering - Investing.com India
VolitionRx announces offering of common stock and warrants, no amount given - TipRanks
15% Overallotment Option: VolitionRx Proposes Underwritten Offering of Common Stock & Warrants - Stock Titan
Live market analysis of VolitionRx LimitedJuly 2025 Decliners & Expert Verified Stock Movement Alerts - newser.com
VolitionRx Limited Stock Analysis and ForecastPrice Momentum Alerts & Build Diversified Portfolios With Ease - earlytimes.in
Is VolitionRx Limited a candidate for recovery playFed Meeting & Reliable Price Action Trade Plans - newser.com
Will a bounce in VolitionRx Limited offer an exit2025 Macro Impact & Real-Time Volume Analysis - newser.com
Is VolitionRX Limited stock resilient in recession scenariosJuly 2025 Setups & Weekly High Return Forecasts - newser.com
Will VolitionRX Limited stock boost dividends furtherNew Guidance & Accurate Buy Signal Notifications - newser.com
Beyond the Genome: Volition Showcases Revolutionary Nu.Q Platform for Epigenetic Drug Discovery - Stock Titan
VolitionRX (NYSEAMERICAN:VNRX) Trading 9% HigherShould You Buy? - MarketBeat
H.C. Wainwright reiterates buy rating on VolitionRX stock at $2.50 By Investing.com - Investing.com Australia
VolitionRX (VNRX) Receives Reiterated Buy Rating by HC Wainwrigh - GuruFocus
Why analysts remain bullish on VolitionRx Limited stockQuarterly Trade Report & Safe Entry Zone Tips - newser.com
VolitionRx Partners with Hologic to Expand Access to Epigenetic Testing Services for Drug Developers - citybuzz
VNRX Stock: Analyst Maintains 'Buy' Rating with $5.00 Price Targ - GuruFocus
What indicators show strength in VolitionRx Limited2025 Volume Leaders & Verified Entry Point Signals - newser.com
Can VolitionRX Limited stock sustain free cash flowLayoff News & Stock Timing and Entry Methods - newser.com
$200M Market Opportunity: Volition Teams with $4B Healthcare Giant Hologic for Epigenetic Testing Service - Stock Titan
What drives VolitionRx Limited stock priceEx-Dividend Date Alerts & Free Popular Stock Picks Selection - earlytimes.in
Institutional scanner results for VolitionRx LimitedGlobal Markets & Accurate Trade Setup Notifications - newser.com
News impact scoring models applied to VolitionRx LimitedJuly 2025 Summary & Expert Approved Trade Ideas - newser.com
Understanding VolitionRx Limited’s price movementWeekly Trade Analysis & Reliable Trade Execution Plans - newser.com
Using Python tools to backtest VolitionRx Limited strategiesMarket Trend Report & Weekly High Conviction Trade Ideas - newser.com
Real time pattern detection on VolitionRx Limited stock2025 Risk Factors & Free Safe Entry Trade Signal Reports - newser.com
VolitionRX Limited (NYSEAMERICAN:VNRX) Sees Large Growth in Short Interest - MarketBeat
How to monitor VolitionRx Limited with trend dashboardsIndex Update & Precise Buy Zone Tips - newser.com
How to use a screener to detect VolitionRx Limited breakoutsJuly 2025 Update & Free Long-Term Investment Growth Plans - newser.com
Signal strength of VolitionRx Limited stock in tech scannersMarket Growth Summary & Stock Portfolio Risk Control - newser.com
Bear Alert: What is the long term forecast for VolitionRx Limited stockMarket Rally & Long-Term Growth Plans - khodrobank.com
Will VolitionRx Limited bounce back from current supportJuly 2025 Recap & Reliable Entry Point Trade Alerts - newser.com
Aug Breakouts: Whats the MACD signal for VolitionRx Limited2025 Short Interest & Technical Confirmation Alerts - خودرو بانک
C O R R E C T I O N -- The FUTR Corporation/17.09.25News - Ariva
VolitionRX Ltd Stock (VNRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
VolitionRX Ltd Stock (VNRX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Innes Guy Archibald | Director |
Aug 05 '25 |
Buy |
0.64 |
78,125 |
50,000 |
966,814 |
Reynolds Cameron John | President and CEO |
Aug 05 '25 |
Buy |
0.64 |
78,125 |
50,000 |
2,609,847 |
Reynolds Cameron John | President and CEO |
Jun 12 '25 |
Buy |
0.59 |
12,500 |
7,372 |
2,331,722 |
Innes Guy Archibald | Director |
Jun 03 '25 |
Buy |
0.54 |
20,000 |
10,772 |
888,689 |
Micallef Jacob Vincent | Chief Scientific Officer |
May 19 '25 |
Buy |
0.43 |
50,000 |
21,500 |
426,033 |
Reynolds Cameron John | President and CEO |
May 19 '25 |
Buy |
0.44 |
20,000 |
8,730 |
2,319,222 |
Reynolds Cameron John | President and CEO |
Mar 26 '25 |
Buy |
0.55 |
181,818 |
100,000 |
2,299,222 |
Innes Guy Archibald | Director |
Mar 26 '25 |
Buy |
0.55 |
181,818 |
100,000 |
868,689 |
Innes Guy Archibald | Director |
Dec 09 '24 |
Buy |
0.57 |
174,764 |
100,000 |
617,085 |
STILL TIMOTHY I | Director |
Dec 09 '24 |
Buy |
0.57 |
87,382 |
50,000 |
1,487,382 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):